The results of the 2024 US presidential election have been announced, and Trump has been elected as the new president and CEO of Accorto, an American compliance company. Tom Beaudet examines the effects of past bipartisan policies. He predicts that the FDA will improve the review process in the future and that vape brands will get market access licenses faster.
Donald Trump has announced the results of the 2024 US presidential election (Donald John Trump is the new president of the United States). The United States is the world’s largest vape market, and its market trends and regulatory policies have global bellwether significance. How the new administration will control vapes and how the U.S. vape market will develop. These issues have attracted the attention of the global industry. As the world’s leading fogging technology media and think tank, the two supreme 2Firsts have contacted American compliance experts for the first time to bring the most authoritative explanation.
AccortoCEO Tom 2Firstst2Beaudet, a U.S. compliance firm, reviewed the attitudes and measures taken by the Trump and Democratic administrations toward vape regulatory policies. He stressed that the government had only approved nine applications for planting new mitigation commodities in four years, with millions of applications submitted. He predicted that the FDA could gradually refine clear market access models during the next administration term, helping companies that submit complete scientific data get market access approvals more quickly.
Here’s what Tom had to say about the entire Beaudet article:
- A few weeks ago, former President Donald Trump said he “saved” a flavored brand in 2020 and would protect those flavored goods again if re-elected. However, it should be noted that under the Trump presidency, closed smoke bomb systems were banned.
- In the past four years, the FDA has approved only nine new harm-reduction products, even though millions of new products have been submitted. Although most of the applications were not attached to the scientific data required for substantive review by the CTP’s Center for Tobacco Products (Office of Science), several companies submitted high-quality applications and are still awaiting a final decision. Many have questioned whether we would have seen a different outcome under another Democratic administration.
- Whatever the outcome of the election on November 5, there is still hope. Under the leadership of Tony Abud, President of the Vapor Technology Association, the association has been active in educating lawmakers of both parties about the importance of tobacco tar in reducing the harm to commodity lives and the importance of improving the FDA to fix the current inadequate approval process. Regardless of who wins tomorrow, we want to improve the approval process for PMTA to ensure that goods submitting high-quality applications have a clear path to market access.” As more products are approved and a library of precedents is established, the path to success will become clearer.
Statement:
[1] The opinions expressed here are those of the experts themselves.
[2] Please refer to the original English version.
Read the original in English here
